Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): Effects of raloxifene, on Endoglin and ALK1 expression in endothelial cells

V Albiñana, ME Bernabeu-Herrero… - Thrombosis and …, 2010 - thieme-connect.com
Hereditary haemorrhagic telangiectasia (HHT), or Rendu-Osler-Weber syndrome, is an
autosomal dominant vascular disease. The clinical manifestations are epistaxis, mucocutaneous …

Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome

ME Bernabéu-Herrero, M Jiménez-Alcázar, J Anter… - Molecular …, 2015 - Elsevier
Atypical hemolytic uremic syndrome (aHUS) is a severe thrombotic microangiopathy affecting
the renal microvasculature and is associated with complement dysregulation caused by …

Mutational and phenotypic characterization of hereditary hemorrhagic telangiectasia

…, K Megy, ME Bernabeu-Herrero… - Blood, The Journal …, 2020 - ashpublications.org
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular dysplasia.
Care delivery for HHT patients is impeded by the need for laborious, repeated phenotyping …

[PDF][PDF] Functional filter for whole-genome sequencing data identifies HHT and stress-associated non-coding SMAD4 polyadenylation site variants> 5 kb from coding …

…, D Patel, AM Bielowka, ME Bernabeu-Herrero… - The American Journal of …, 2023 - cell.com
Despite whole-genome sequencing (WGS), many cases of single-gene disorders remain
unsolved, impeding diagnosis and preventative care for people whose disease-causing …

Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome

P Nozal, ME Bernabéu-Herrero, B Uzonyi… - Molecular …, 2016 - Elsevier
… Author links open overlay panel Pilar Nozal a b 1 , Maria E. Bernabéu-Herrero b c 1 , Barbara
Uzonyi d 1 , Ágnes Szilágyi e , Satu Hyvärinen f , Zoltán Prohászka e , T. Sakari Jokiranta f …

Mutation study of Spanish patients with hereditary hemorrhagic telangiectasia

…, A Perez-Molino, ME Bernabeu-Herrero… - BMC Medical …, 2008 - Springer
Background Hereditary Hemorrhagic Telangiectasia (HHT) is an autosomal dominant and
age-dependent vascular disorder characterised mainly by mutations in the Endoglin (ENG) or …

MEK 1 inhibition and bleeding in hereditary haemorrhagic telangiectasia

…, ME BernabeuHerrero… - British Journal of …, 2024 - Wiley Online Library
Hereditary haemorrhagic telangiectasia (HHT) affects approximately 1.5 million individuals
worldwide, results from a germline loss-of-function gene variant (‘mutation’) usually in ENG, …

Mutations causing premature termination codons discriminate and generate cellular and clinical variability in HHT

ME Bernabéu-Herrero, D Patel, A Bielowka… - Blood …, 2024 - ashpublications.org
For monogenic diseases caused by pathogenic loss-of-function DNA variants, attention
focuses on dysregulated gene-specific pathways, usually considering molecular subtypes …

Functional filter for whole genome sequence data identifies stress impact, non-coding, alternate polyadenylation site variants> 5kb from coding DNA

…, D Li, D Patel, A Bielowka, ME Bernabeu-Herrero… - medRxiv, 2023 - medrxiv.org
Despite whole genome sequencing (WGS), why do many single gene disorder cases
remain unsolved, impeding diagnosis and preventative care for people whose disease-causing …

Heterozygous transcriptional and nonsense decay signatures in blood outgrowth endothelial cells from patients with hereditary haemorrhagic telangiectasia

ME Bernabeu-Herrero, D Patel, A Bielowka, S Srikaran… - bioRxiv, 2021 - biorxiv.org
In order to identify cellular phenotypes resulting from nonsense (gain of stop/premature
termination codon) variants, we devised a framework of analytic methods that minimised …